Mylan and its CEO Heather Bresch are making worse than a mockery out of business and pharma ethics, not to mention putting lives at risk. The development of the EpiPen was supported 100% by the gov. They lobbied to have laws passed requiring schools to buy EpiPens. Brilliant. That lobbyist became CEO in spite of not having the degree she claimed. She is now making a healthy 8 figure income after hiking the price every other other quarter, now at $600. And the med expires in 12-18 months, requiring another purchase. To add injury to injury, they moved their HQ out of the country to dodge taxes. The company is already in damage control mode, though the response is token.
Much of Mylan’s business is in generic drugs e.g. penicillin. Almost every generic drug is made by more than one company, I believe. Therefore, it should be simple for consumers to insist on non-Mylan generic drugs. Take a look. www.mylan.com/…
As far as their non-generics (“proprietary”), there are very few drugs that are truly original and important in their own right...most proprietary drugs are just minor variations on the original patented drug. So most non-generics are also susceptible to consumer boycott.
Physicians of conscience would gladly join such a boycott. Realistically, the sales of most of their products could be cut in half. No company can tolerate that.
Heather Bresch should resign. The Epipen should be selling for under a hundred bucks. Consumers and doctors could make these things happen.